SIMCERE PHARMACEUTICAL GROUP Current Income Tax Expense (Benefit)
SIMCERE PHARMACEUTICAL GROUP reported Current Income Tax Expense (Benefit) of CNY 35.91 million for the 12-month period ending 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2013-04-26
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2012-12-31 | 35.91M CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 30.84M CNY 20-F · filed 2013-04-26 |
| 2010-12-31 | 38.36M CNY 20-F · filed 2013-04-26 |